Compare HMN & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HMN | ENOV |
|---|---|---|
| Founded | 1945 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Fluid Controls |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1991 | 2008 |
| Metric | HMN | ENOV |
|---|---|---|
| Price | $42.53 | $24.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $46.75 | ★ $48.13 |
| AVG Volume (30 Days) | 233.6K | ★ 969.8K |
| Earning Date | 02-03-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | ★ 56.80 | N/A |
| EPS | ★ 3.95 | N/A |
| Revenue | $1,675,600,000.00 | ★ $2,233,266,000.00 |
| Revenue This Year | $7.70 | $9.22 |
| Revenue Next Year | $6.46 | $4.60 |
| P/E Ratio | $10.75 | ★ N/A |
| Revenue Growth | 5.44 | ★ 11.57 |
| 52 Week Low | $37.21 | $23.58 |
| 52 Week High | $48.33 | $49.38 |
| Indicator | HMN | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 29.16 | 35.40 |
| Support Level | $44.18 | $23.58 |
| Resistance Level | $46.19 | $24.94 |
| Average True Range (ATR) | 1.06 | 1.33 |
| MACD | -0.38 | -0.32 |
| Stochastic Oscillator | 6.75 | 7.29 |
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.